South Africa Blood-based Biomaker For Sports Medicine Market Size & Outlook
South Africa blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
South Africa blood-based biomaker for sports medicine market highlights
- The South Africa blood-based biomaker for sports medicine market generated a revenue of USD 4.9 million in 2023 and is expected to reach USD 7.0 million by 2030.
- The South Africa market is expected to grow at a CAGR of 5.2% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 4.9 million |
| Market revenue in 2030 | USD 7.0 million |
| Growth rate | 5.2% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.7% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 6.7 million by 2030.
Ck was the largest segment with a revenue share of 18.37% in 2023. Horizon Databook has segmented the South Africa blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In South Africa, sports injury prevalence, particularly concussions, is a significant concern. According to a BMJ Journal report from February 2022, concussion was the most frequently diagnosed injury among South African university rugby students, accounting for 27 out of 90 injuries (30%). The concussion rate was 9 per 1,000 match hours.
This high concussion rate highlights the growing need for advanced medical solutions in sports medicine. Moreover, with a growing awareness of the prevalence and impact of sports injuries, including concussions, there is an enhanced demand for advanced medical technologies. Blood-based biomarkers are becoming integral in this context, offering valuable insights into injury severity, recovery progress, and overall athlete well-being.
In South Africa, government funding for research in biomarkers is on the rise, reflecting an increased focus on improving sports medicine and athlete health. This funding supports the development and application of blood-based biomarkers, which are crucial for monitoring and managing sports injuries.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
South Africa Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
